Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
There is no doubt the pandemic intensified and exacerbated an already stressed healthcare workforce. On the frontlines and across healthcare organizations, supporting healthcare workers...
In part 2 of our podcast series, A&M's Larry Kaiser, M.D., FACS and Marthe Haverkamp, M.D., Ph.D, talk with Kevin Mahoney, CEO, University of...
The recent rise in labor costs is impacting operations for U.S. healthcare organizations. Listen to A&M Healthcare Industry Group's latest podcast to learn how...
